Neurotronic
Manufacturing · Minnesota, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
13705 26th Ave N Ste 102, Minneapolis, M...Website
www.neurotronic.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Neurotronic
Neurotronic is focused on developing innovative therapies for individuals suffering from type 2 diabetes and hypertension. Their primary product, Neuviant Multi-organ Denervation (MDN), is an investigational treatment designed to reduce blood sugar and blood pressure through a single procedure targeting overactive nerves in the kidneys and liver. The company aims to assist patients who struggle to control their conditions despite following traditional lifestyle and medication recommendations. Neurotronic is currently preparing to enroll participants for clinical studies in the United States.Explore more
Popular SearchesNeurotronicNeurotronic.comSIC Code 28,283NAICS Code 32,325Show moreNeurotronic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurotronic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Neurotronic had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Neurotronic has new funding data
Product Launch: Get notified when Neurotronic launches new products
Website visits: Recent activity has been detected on your website
Check if Neurotronic has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Neurotronic recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Neurotronic
Check out if Neurotronic is spiking on competitors!
Neurotronic, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Neurotronic is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurotronic is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurotronic.
Neurotronic Tech Stack
A closer look at the technologies used by Neurotronic
See more technologies
Neurotronic News & Media
Neurotronic Announces First Clinical Outcomes of Multi‑Organ Denervation for Type 2 Diabetes and Hypertension
Groundbreaking results from two NECTAR trials to be presented at TCT 2025 SAN FRANCISCO, Oct. 24, 2025 /PRNewswire/ -- Neurotronic, Inc., a developer of multi-organ denervation to treat complex cardiovascular and metabolic disease, announced today the upcoming presentations of the first...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurotronic
Sign Up For FreeTo access detailed company insights
Neurotronic is focused on developing innovative therapies for individuals suffering from type 2 diabetes and hypertension. Their primary product, Neuviant Multi-organ Denervation (MDN), is an investigational treatment designed to reduce blood sugar and blood pressure through a single procedure targeting overactive nerves in the kidneys and liver. T... Read More
